File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: SGLT2 Inhibitor Empagliflozin: Finally at the Latter Stage of Understanding

TitleSGLT2 Inhibitor Empagliflozin: Finally at the Latter Stage of Understanding
Authors
Chan, GCWTang, SCW
Issue Date2017
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/ki/index.html
Citation
Kidney International, 2017, v. 93 n. 1, p. 22-24 How to Cite?
DOI: http://dx.doi.org/10.1016/j.kint.2017.07.008
Persistent Identifierhttp://hdl.handle.net/10722/247548
ISSN
0085-2538
2023 Impact Factor: 14.8
2023 SCImago Journal Rankings: 3.886
ISI Accession Number ID
WOS:000419089400008

 

DC FieldValueLanguage
dc.contributor.authorChan, GCW-
dc.contributor.authorTang, SCW-
dc.date.accessioned2017-10-18T08:28:59Z-
dc.date.available2017-10-18T08:28:59Z-
dc.date.issued2017-
dc.identifier.citationKidney International, 2017, v. 93 n. 1, p. 22-24-
dc.identifier.issn0085-2538-
dc.identifier.urihttp://hdl.handle.net/10722/247548-
dc.languageeng-
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/ki/index.html-
dc.relation.ispartofKidney International-
dc.titleSGLT2 Inhibitor Empagliflozin: Finally at the Latter Stage of Understanding-
dc.typeArticle-
dc.identifier.emailChan, GCW: gcwchan1@hku.hk-
dc.identifier.emailTang, SCW: scwtang@hku.hk-
dc.identifier.authorityTang, SCW=rp00480-
dc.identifier.doi10.1016/j.kint.2017.07.008-
dc.identifier.scopuseid_2-s2.0-85039945200-
dc.identifier.hkuros282374-
dc.identifier.volume93-
dc.identifier.issue1-
dc.identifier.spage22-
dc.identifier.epage24-
dc.identifier.isiWOS:000419089400008-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0085-2538-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats